Baudax Bio Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Baudax Bio prevailing Real Value cannot be determined due to lack of data. The current price of Baudax Bio is $0.0. Our model approximates the value of Baudax Bio from analyzing the firm fundamentals such as Operating Margin of (27.60) %, shares outstanding of 43.59 M, and Return On Equity of -47.04 as well as examining its technical indicators and probability of bankruptcy.
Baudax Bio Total Value Analysis
Baudax Bio is currently projected to have valuation of 17.72 M with market capitalization of 950.33 K, debt of 7.12 M, and cash on hands of 5.65 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Baudax Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.72 M | 950.33 K | 7.12 M | 5.65 M |
Baudax Bio Investor Information
The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Baudax Bio recorded a loss per share of 94.13. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 1st of December 2022. Based on the analysis of Baudax Bio's profitability, liquidity, and operating efficiency, Baudax Bio is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Baudax Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Baudax Bio has an asset utilization ratio of 12.65 percent. This suggests that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that Baudax Bio is more efficient with each dollar of assets it utilizes for everyday operations.Baudax Bio Ownership Allocation
Baudax Bio holds a total of 43.59 Million outstanding shares. Almost 97.31 percent of Baudax Bio outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 2.68 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Baudax Bio Profitability Analysis
The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M).Baudax Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 331.6 K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Baudax Stock
If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |